Drug
Cemdisiran
Cemdisiran: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| cemdisiran NCT03999840 | Phase 2 | Atypical Hemolytic Uremic Syndrome |
Latest
No recent events.
Follow Cemdisiran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.